Expedia Group Reports Third Quarter 2025 Results Exceeded guidance with 12% bookings and 9% revenue growth y/y; expanded Adj. EBITDA margins Room nights up 11% y/y, driven by B2B and B2C strength in the U.S. Repurchased $451 million of shares in the quarter; declares dividend of $0.40 per share Increases full year guidance SEATTLE, WA – November 6, 2025 – Expedia Group, Inc. (NASDAQ: EXPE) announced financial results today for the third quarter ended September 30, 2025. Third Quarter Highlights (All compari ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 1-36346 OXBRIDGE RE HOLDINGS LIMITED (Exact name of registrant as specified in its charter) | Cayman Islands ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14895 SAREPTA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 93-0797222 (State or other ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-36557 ADVANCED DRAINAGE SYSTEMS, INC. (Exact name of registrant as specified in its charter) (State or Other Jurisdiction of Incorporation or Organization) D ...

Financial Performance - For the nine months ended September 30, 2025, the Company reported revenue of $1,049,125, a decrease of 9.4% compared to $1,157,380 for the same period in 2024[28] - Operating loss for the nine months ended September 30, 2025, was $(1,358,625), compared to $(817,589) for the same period in 2024, indicating a significant increase in losses[28] - Employee compensation expenses rose to $834,855 for the nine months ended September 30, 2025, up 11.8% from $746,582 in 2024[28] - Two significant European licensees filed for bankruptcy, accounting for approximately 44% of the Company's revenue during the nine months ended September 30, 2025[46] - The Company has not recorded income tax expense since inception due to ongoing operating losses[47] Revenue Recognition - The Company recognized revenue based on the satisfaction of performance obligations, with a variable royalty fee structure typically ranging from 10-15% of the selling price[38] - During the first nine months of 2025, five licensees accounted for approximately 23%, 22%, 21%, 18%, and 11% of fee income, compared to four licensees accounting for 32%, 31%, 10%, and 10% in 2024[44] - Fee income from Gauzy and Vision Systems represented 13% of the Company’s total fee income for the nine months ended September 30, 2025[58] - Accounts receivable from Gauzy and Vision Systems represented 17% of the Company’s total royalty receivables as of September 30, 2025[58] Share-Based Compensation - The Company recorded share-based compensation of $175,204 during the nine months ended September 30, 2025, related to stock options granted[52] - The fair value of the stock options granted was $1.265, with an expected volatility of 76% and a risk-free interest rate of 3.97%[53] - As of September 30, 2025, the Company had 1,630,434 warrants and 1,281,489 options outstanding[53] - No options or warrants were exercised during the nine-month period ended September 30, 2025[49] Lease Obligations - The Company’s operating lease has a remaining term of 6.3 years as of September 30, 2025, with total lease payments amounting to $1,497,000[55][57] - The incremental borrowing rate for the operating lease increased from 5.5% in 2024 to 7.0% in 2025[55] - Cash rent paid for the nine months ended September 30, 2025, was $163,000, compared to $174,000 for the same period in 2024[55] - The initial term of the operating lease expires on December 31, 2027, with potential renewal options extending to December 31, 2031[55] Other Financial Information - The Company had $37,736 in unbilled revenue included in royalty receivables as of September 30, 2025[40] - The Company received $47,357 in Employee Retention Credits during the nine months ended September 30, 2025, compared to $35,152 in 2024[59] - There has been no material change in the disclosure regarding market risk since the last annual report[86]

Product Development - The company introduced over 100 new products in the fiscal year ended June 30, 2025, and 16 new products during the three months ended September 30, 2025, expanding its portfolio to approximately 2,800 products[89] - The company has a patent portfolio consisting of 951 patents and 71 patent applications in the United States, along with 1,067 foreign patents as of September 30, 2025[89] - Research and development expenses are critical for long-term success, with ongoing investments in new technologies and products[109] Financial Performance - Total revenue for the three months ended September 30, 2025, was $182.5 million, an increase of $0.6 million, or 0.3%, compared to $181.9 million for the same quarter last year[124] - Gross profit for the three months ended September 30, 2025, was $42.8 million, a decrease of $1.7 million, or 3.8%, compared to $44.5 million for the same quarter last year[125] - Operating loss for the three months ended September 30, 2025, was $(4.6) million, compared to $(0.3) million for the same quarter last year[122] - Net loss for the three months ended September 30, 2025, was $(2.1) million, compared to $(2.5) million for the same quarter last year[122] Market Impact - The company’s revenue is significantly affected by the PC market, which has experienced a modest global decline, impacting revenue and results of operations[96] - The company is diversifying its product portfolio to reduce reliance on the PC market and improve gross margins through cost control measures[97] Expenses and Costs - The company’s gross margin is influenced by manufacturing costs, capacity utilization, and pricing from third-party foundries[98] - Operating expenses are expected to fluctuate as a percentage of revenue due to cost control measures in response to the declining PC market[108] - Research and development expenses were $24.1 million, an increase of $1.7 million, or 7.4%, compared to $22.5 million for the same quarter last year[126] - Selling, general and administrative expenses increased to $23.3 million for the three months ended September 30, 2025, up by $1.0 million or 4.4% from $22.3 million in the same quarter last year[127] Joint Venture and Investments - The company expects to receive $150 million from the sale of approximately 20.3% of its equity interest in a joint venture, with the first installment of RMB 676 million (or $94.5 million) already received[94] - As of June 30, 2025, the company's ownership interest in the joint venture was reduced to 39.2% after several transactions[93] - An impairment loss of $76.8 million was recorded within equity method investment loss in the fourth quarter of fiscal year 2025[120] - Equity method investment income increased to $1.4 million in Q3 2025, compared to a loss of $1.0 million in Q3 2024, reflecting a change of $2.4 million or 237.9%[132] Cash Flow - Cash, cash equivalents, and restricted cash totaled $223.9 million as of September 30, 2025, up from $153.5 million as of June 30, 2025[142] - Net cash provided by operating activities was $10.2 million in Q3 2025, a decrease of $0.8 million from $11.0 million in Q3 2024[143] - Net cash provided by investing activities increased to $81.9 million in Q3 2025, compared to a cash outflow of $6.7 million in Q3 2024, reflecting a change of $88.7 million[145] - Net increase in cash, cash equivalents, and restricted cash was $70.4 million in Q3 2025, compared to an increase of $0.7 million in Q3 2024[143] Taxation - The effective tax rate is highly dependent on the geographic distribution of worldwide profits or losses and changes in tax laws[114] - A potential 15% corporate income tax may apply to Bermuda companies starting from tax years beginning on or after January 1, 2025, affecting the company's financial position[115] Other Income and Expenses - Other income (loss), net improved to $2.5 million in Q3 2025, compared to a loss of $0.7 million in Q3 2024, representing a change of $3.1 million or 479.7%[128] - Interest income decreased to $0.9 million in Q3 2025, down by $0.4 million or 29.5% from $1.3 million in Q3 2024 due to lower interest rates[130] - Interest expenses decreased to $0.4 million in Q3 2025, down by $0.5 million or 55.7% from $0.8 million in Q3 2024, primarily due to a lower outstanding loan balance[131] - Income tax expense rose to approximately $1.9 million in Q3 2025, an increase of $0.9 million or 85.3% from $1.0 million in Q3 2024[133] Market Risks - No material changes in market risks were reported compared to the previous disclosures in the Annual Report for the year ended June 30, 2025[150]

News Release IREN Reports Q1 FY26 Results Secured $9.7bn AI Cloud Contract with Microsoft Targeting $3.4bn AI Cloud ARR by End of 2026, Expansion to 140k GPUs1 NEW YORK, November 6, 2025 (GLOBE NEWSWIRE) - IREN Limited (NASDAQ: IREN) ("IREN" or "the Company") today reported its financial results for the three months ended September 30, 2025. Highlights Q1 FY26 Financial Results * Includes unrealized gains, primarily on prepaid forwards and capped calls in connection with convertible notes Project Update Bri ...

Peloton Announces Q1 2026 Financial Results, Raises Full Year 2026 Adjusted EBITDA Guidance Cash Provided by Operating Activities was $72 million; Free Cash Flow* was $67 million, an increase of $57 million year-over-year NEW YORK, NY – November 6, 2025 – Peloton Interactive, Inc. today reported financial results for the quarter ended September 30, 2025. Q1 FY2026 Financial Highlights "In this quarter leading up to the launch of our new equipment lineup and Peloton IQ, our team once again demonstrated the p ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission File No. 001-41961 Unusual Machines, Inc. (Exact Name of Registrant as Specified in Its Charter) (State o ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q _________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number 001-41109 INTENSITY THERAPEUTICS, INC. (Exact name of registra ...